LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Macrophage Nanoparticles Created as Sepsis Treatment

By LabMedica International staff writers
Posted on 16 Jan 2018
Image: An artist illustration of nanoparticles coated with macrophage cell membranes (Photo courtesy of Nanomaterials & Nanomedicine Laboratory, University of California, San Diego).
Image: An artist illustration of nanoparticles coated with macrophage cell membranes (Photo courtesy of Nanomaterials & Nanomedicine Laboratory, University of California, San Diego).
A novel approach for treating sepsis is based on nanoparticles (so-called nanosponges) coated with cell membranes isolated from immune macrophages.

Sepsis is a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs. Sepsis is caused by an immune response triggered by an infection. Most commonly, the infection is bacterial, but it may also be from fungi, viruses, or parasites. Common locations for the primary infection include lungs, brain, urinary tract, skin, and abdominal organs.

Currently, there are no effective clinically available sepsis treatments, and care remains primarily supportive. In an effort to develop an effective sepsis treatment, investigators at the University of California, San Diego (USA) fabricated a novel type of macrophage biomimetic nanoparticle or nanosponge. The nanoparticles, made by wrapping polymeric cores with cell membrane derived from macrophages, possessed an antigenic exterior the same as the source cells.

The investigators reported in the October 24, 2017, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences that by acting as macrophage decoys, these nanoparticles bound and neutralized endotoxins that would otherwise have triggered immune activation. In addition, these macrophage-like nanoparticles sequestered proinflammatory cytokines and inhibited their ability to potentiate the sepsis cascade.

In a mouse Escherichia coli bacteremia model, treatment with macrophage mimicking nanoparticles, termed M-Phi-NPs, reduced proinflammatory cytokine levels, inhibited bacterial dissemination, and ultimately conferred a significant survival advantage to infected mice.

"A wide range of endotoxins and pro-inflammatory cytokines naturally bind to macrophage cell membranes, so these nanosponges serve as universal traps for a broad spectrum of sepsis-causing molecules," said senior author Dr. Liangfang Zhang, professor of nanoengineering at the University of California, San Diego. "They can work across different bacterial genus, species and strains, and since they are covered in actual macrophage cell membranes, they can pass as the body's own immune cells and circulate the bloodstream without being evicted."

Related Links:
University of California, San Diego

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Human Estradiol Assay
Human Estradiol CLIA Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more